Earns most awards globally with wins in 16 categories TORONTO, Nov. 21, 2024 (Korea Bizwire) – Leading global diversified professional services company Colliers (NASDAQ and TSX: CIGI) is proud to be named World’s Best Real Estate Advisor by the prestigious Euromoney Global Real Estate Awards. Building on last year’s Best Global Agency win, Colliers continued [...]
Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the U.S. Ziihera received accelerated approval based on results including a 52% objective response rate and median duration of response of 14.9 months as determined by independent central review (ICR) from the HERIZON-BTC-01 clinical trial $25M milestone payment to be [...]
SINGAPORE, Nov. 21, 2024 (Korea Bizwire) – Bitdeer AI, part of Bitdeer Technologies Group (NASDAQ: BTDR), an emerging AI cloud service provider, is proud to announce its inclusion in the Top 100 Software Companies of 2024, ranked 8 in the Cloud Management by The Software Report. The Software Report’s Top 100 Software Companies award is [...]
OSS, The Netherlands, Nov. 19, 2024 (Korea Bizwire) – Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands, and Sweden, announces the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss. Granted by the Dutch Healthcare Authority, the approval enables GMP manufacturing [...]
SHANGHAI, Nov. 16, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved [...]
Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) One of several biosimilar value drivers for Sandoz Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing global and European leadership Basel, November 15, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced [...]
Hong Kong/Singapore, Nov. 14 (Korea Bizwire) – VistaJet, the world’s first and only global private aviation company, was honored with the title of Best AOC Charter Operator at the prestigious Asian Business Aviation Association (AsBAA) Icons of Aviation Awards. 2024 marks the sixth consecutive year* that VistaJet has been recognized for its industry-leading excellence, service, and [...]
ST. LOUIS, Nov. 13, 2024 (Korea Bizwire) – Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its primary endpoint. ECLIPSE is a pivotal Phase 3, multi-center, open-label, randomized clinical trial comparing the safety and efficacy of 177Lu-PSMA-I&T (INN: lutetium (177Lu) zadavotide guraxetan) versus hormone therapy in patients with metastatic castration-resistant [...]
SAN FRANCISCO, Nov. 13, 2024 (Korea Bizwire) – In a pivotal move for blockchain accessibility, Gala Games announces the integration of GalaChain with Bitrue, making it the first mainstream international exchange to support Gala’s proprietary layer-1 blockchain. Starting November 13, 2024, Bitrue users will be able to directly exchange GalaChain assets, eliminating the need to bridge to Ethereum [...]
COLORADO SPRINGS, Colo., Nov. 12, 2024 (Korea Bizwire) – Performance Review Institute (PRI) Registrar recognizes The Sanborn Map Company, Inc. for having met the stringent requirements of the 9001:2015 international standard, their ongoing commitment to satisfying stakeholders, and their dedication to continual improvement of their management system. The Sanborn Map Company, Inc. announces that it has [...]